291 related articles for article (PubMed ID: 21477942)
1. Internal fiducial markers and susceptibility effects in MRI-simulation and measurement of spatial accuracy.
Jonsson JH; Garpebring A; Karlsson MG; Nyholm T
Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):1612-8. PubMed ID: 21477942
[TBL] [Abstract][Full Text] [Related]
2. Characterization of a novel liquid fiducial marker for multimodal image guidance in stereotactic body radiotherapy of prostate cancer.
De Roover R; Crijns W; Poels K; Peeters R; Draulans C; Haustermans K; Depuydt T
Med Phys; 2018 May; 45(5):2205-2217. PubMed ID: 29537613
[TBL] [Abstract][Full Text] [Related]
3. Fiducial marker for prostate radiotherapy: comparison of 0.35- and 0.5-mm-diameter computed tomography and magnetic resonance images.
Tanaka O; Komeda H; Iida T; Tamaki M; Seike K; Kato D; Hirose S; Kawaguchi D; Yokoyama T
Radiol Med; 2017 Mar; 122(3):204-207. PubMed ID: 27981486
[TBL] [Abstract][Full Text] [Related]
4. MRI-alone radiation therapy planning for prostate cancer: Automatic fiducial marker detection.
Ghose S; Mitra J; Rivest-Hénault D; Fazlollahi A; Stanwell P; Pichler P; Sun J; Fripp J; Greer PB; Dowling JA
Med Phys; 2016 May; 43(5):2218. PubMed ID: 27147334
[TBL] [Abstract][Full Text] [Related]
5. Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI.
Gurney-Champion OJ; Lens E; van der Horst A; Houweling AC; Klaassen R; van Hooft JE; Stoker J; van Tienhoven G; Nederveen AJ; Bel A
Med Phys; 2015 May; 42(5):2638-47. PubMed ID: 25979055
[TBL] [Abstract][Full Text] [Related]
6. Quantification of fiducial marker visibility for MRI-only prostate radiotherapy simulation.
Singhrao K; Ruan D; Fu J; Gao Y; Chee G; Yang Y; King C; Hu P; Kishan AU; Lewis JH
Phys Med Biol; 2020 Feb; 65(3):035015. PubMed ID: 31881546
[TBL] [Abstract][Full Text] [Related]
7. Automatic Substitute Computed Tomography Generation and Contouring for Magnetic Resonance Imaging (MRI)-Alone External Beam Radiation Therapy From Standard MRI Sequences.
Dowling JA; Sun J; Pichler P; Rivest-Hénault D; Ghose S; Richardson H; Wratten C; Martin J; Arm J; Best L; Chandra SS; Fripp J; Menk FW; Greer PB
Int J Radiat Oncol Biol Phys; 2015 Dec; 93(5):1144-53. PubMed ID: 26581150
[TBL] [Abstract][Full Text] [Related]
8. Using C-Arm X-ray images from marker insertion to confirm the gold fiducial marker identification in an MRI-only prostate radiotherapy workflow.
Gustafsson C; Persson E; Gunnlaugsson A; Olsson LE
J Appl Clin Med Phys; 2018 Nov; 19(6):185-192. PubMed ID: 30354010
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy.
Maspero M; Seevinck PR; Willems NJW; Sikkes GG; de Kogel GJ; de Boer HCJ; van der Voort van Zyp JRN; van den Berg CAT
Radiat Oncol; 2018 Jun; 13(1):105. PubMed ID: 29871656
[TBL] [Abstract][Full Text] [Related]
10. Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging.
Osman SOS; Russell E; King RB; Crowther K; Jain S; McGrath C; Hounsell AR; Prise KM; McGarry CK
Radiat Oncol; 2019 Dec; 14(1):237. PubMed ID: 31878967
[TBL] [Abstract][Full Text] [Related]
11. Qualitative evaluation of fiducial markers for radiotherapy imaging.
Chan MF; Cohen GN; Deasy JO
Technol Cancer Res Treat; 2015 Jun; 14(3):298-304. PubMed ID: 25230715
[TBL] [Abstract][Full Text] [Related]
12. Registration free automatic identification of gold fiducial markers in MRI target delineation images for prostate radiotherapy.
Gustafsson C; Korhonen J; Persson E; Gunnlaugsson A; Nyholm T; Olsson LE
Med Phys; 2017 Nov; 44(11):5563-5574. PubMed ID: 28803447
[TBL] [Abstract][Full Text] [Related]
13. Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
Pathmanathan AU; Schmidt MA; Brand DH; Kousi E; van As NJ; Tree AC
J Appl Clin Med Phys; 2019 Mar; 20(3):27-36. PubMed ID: 30756456
[TBL] [Abstract][Full Text] [Related]
14. Development of multiorgan finite element-based prostate deformation model enabling registration of endorectal coil magnetic resonance imaging for radiotherapy planning.
Hensel JM; Ménard C; Chung PW; Milosevic MF; Kirilova A; Moseley JL; Haider MA; Brock KK
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1522-8. PubMed ID: 17674983
[TBL] [Abstract][Full Text] [Related]
15. Magnetic resonance imaging in the radiation treatment planning of localized prostate cancer using intra-prostatic fiducial markers for computed tomography co-registration.
Parker CC; Damyanovich A; Haycocks T; Haider M; Bayley A; Catton CN
Radiother Oncol; 2003 Feb; 66(2):217-24. PubMed ID: 12648794
[TBL] [Abstract][Full Text] [Related]
16. Position verification for the prostate: effect on rectal wall dose.
Haverkort MA; van de Kamer JB; Pieters BR; van Tienhoven G; Assendelft E; Lensing AL; van Herk M; de Reijke TM; Stoker J; Koning CC
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):462-8. PubMed ID: 20646865
[TBL] [Abstract][Full Text] [Related]
17. First clinical release of an online, adaptive, aperture-based image-guided radiotherapy strategy in intensity-modulated radiotherapy to correct for inter- and intrafractional rotations of the prostate.
Deutschmann H; Kametriser G; Steininger P; Scherer P; Schöller H; Gaisberger C; Mooslechner M; Mitterlechner B; Weichenberger H; Fastner G; Wurstbauer K; Jeschke S; Forstner R; Sedlmayer F
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):1624-32. PubMed ID: 22209149
[TBL] [Abstract][Full Text] [Related]
18. MRI-based treatment planning for radiotherapy: dosimetric verification for prostate IMRT.
Chen L; Price RA; Wang L; Li J; Qin L; McNeeley S; Ma CM; Freedman GM; Pollack A
Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):636-47. PubMed ID: 15380601
[TBL] [Abstract][Full Text] [Related]
19. Dosimetric and workflow evaluation of first commercial synthetic CT software for clinical use in pelvis.
Tyagi N; Fontenla S; Zhang J; Cloutier M; Kadbi M; Mechalakos J; Zelefsky M; Deasy J; Hunt M
Phys Med Biol; 2017 Apr; 62(8):2961-2975. PubMed ID: 27983520
[TBL] [Abstract][Full Text] [Related]
20. Visualization of gold fiducial markers in the prostate using phase-cycled bSSFP imaging for MRI-only radiotherapy.
Shcherbakova Y; Bartels LW; Mandija S; Beld E; Seevinck PR; van der Voort van Zyp JRN; Kerkmeijer LGW; Moonen CTW; Lagendijk JJW; van den Berg CAT
Phys Med Biol; 2019 Sep; 64(18):185001. PubMed ID: 31344696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
